loading
Sonoma Pharmaceuticals Inc stock is traded at $4.13, with a volume of 21,727. It is up +1.47% in the last 24 hours and down -6.77% over the past month. Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
See More
Previous Close:
$4.07
Open:
$4.07
24h Volume:
21,727
Relative Volume:
0.02
Market Cap:
$6.79M
Revenue:
$12.31M
Net Income/Loss:
$-5.08M
P/E Ratio:
-4.3936
EPS:
-0.94
Net Cash Flow:
$-5.20M
1W Performance:
-0.96%
1M Performance:
-6.77%
6M Performance:
+58.85%
1Y Performance:
+40.48%
1-Day Range:
Value
$3.95
$4.15
1-Week Range:
Value
$3.91
$4.44
52-Week Range:
Value
$1.75
$6.9199

Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile

Name
Name
Sonoma Pharmaceuticals Inc
Name
Phone
800-759-9305
Name
Address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Name
Employee
168
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
SNOA's Discussions on Twitter

Compare SNOA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
SNOA
Sonoma Pharmaceuticals Inc
4.13 6.71M 12.31M -5.08M -5.20M -0.94
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
142.62 63.58B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.89 43.58B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.2058 40.83B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
19.95 23.07B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
440.49 19.61B 3.08B 1.24B 1.07B 25.61

Sonoma Pharmaceuticals Inc Stock (SNOA) Latest News

pulisher
Oct 14, 2025

Can Sonoma Pharmaceuticals Inc. (O8Z) stock sustain double digit ROEMarket Volume Report & Weekly Top Stock Performers List - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

How Sonoma Pharmaceuticals Inc. stock performs in interest rate cyclesJuly 2025 Technicals & Stepwise Entry/Exit Trade Alerts - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Sonoma Pharmaceuticals Inc. stock trendline breakdownFed Meeting & Real-Time Sentiment Analysis - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Sonoma Pharmaceuticals (SNOA) Collaborates with Medline for New Wound Cleanser Distribution - GuruFocus

Oct 14, 2025
pulisher
Oct 14, 2025

Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals - ACCESS Newswire

Oct 14, 2025
pulisher
Oct 14, 2025

How institutional ownership impacts Sonoma Pharmaceuticals Inc. stock2025 Performance Recap & Weekly High Momentum Picks - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Is Sonoma Pharmaceuticals Inc. stock a buy for dividend growth2025 Momentum Check & Verified High Yield Trade Plans - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Analyzing net buyer seller activity in Sonoma Pharmaceuticals Inc.Weekly Trend Summary & Entry Point Confirmation Signals - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

How Sonoma Pharmaceuticals Inc. stock benefits from tech adoption2025 Geopolitical Influence & Capital Protection Trading Alerts - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Earnings visualization tools for Sonoma Pharmaceuticals Inc.Dip Buying & Stock Portfolio Risk Management - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Is Sonoma Pharmaceuticals Inc. stock in correction or buying zonePortfolio Gains Report & Daily Stock Trend Reports - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Will Sonoma Pharmaceuticals Inc. stock attract more institutional investors2025 Dividend Review & Growth-Oriented Investment Plans - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Can Sonoma Pharmaceuticals Inc. stock reach $100 price targetQuarterly Portfolio Report & Reliable Breakout Forecasts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Is Sonoma Pharmaceuticals Inc. (O8Z) stock trading at attractive multiplesJuly 2025 Sector Moves & Reliable Breakout Forecasts - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

What analysts say about Sonoma Pharmaceuticals Inc stockGeopolitical Risk Analysis & Exceptional Return Stocks - earlytimes.in

Oct 12, 2025
pulisher
Oct 11, 2025

Why Sonoma Pharmaceuticals Inc. (O8Z) stock is favored by hedge fundsTrade Entry Report & Risk Managed Investment Strategies - newser.com

Oct 11, 2025
pulisher
Oct 11, 2025

Sonoma Pharmaceuticals registers HOCl facial spray under U.S. cosmetics law - MSN

Oct 11, 2025
pulisher
Oct 10, 2025

Sonoma Pharmaceuticals Inc. recovery potential after sell off2025 Price Momentum & Risk Controlled Daily Trade Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Using RSI to spot recovery in Sonoma Pharmaceuticals Inc.2025 Key Lessons & Weekly Watchlist for Hot Stocks - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is Sonoma Pharmaceuticals Inc. stock attractive for long term wealth buildingEarnings Summary Report & Intraday High Probability Setup Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Will Sonoma Pharmaceuticals Inc. rebound enough to break even2025 Price Momentum & Community Driven Trade Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Analyzing Sonoma Pharmaceuticals Inc. with risk reward ratio chartsEarnings Beat & Technical Pattern Alert System - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Tools to assess Sonoma Pharmaceuticals Inc.’s risk profileJuly 2025 Action & Risk Managed Trade Strategies - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Real time scanner hits for Sonoma Pharmaceuticals Inc. explainedRate Hike & AI Powered Buy and Sell Recommendations - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Sonoma Pharmaceuticals’ (SNOA) Sell (D-) Rating Reiterated at Weiss Ratings - Defense World

Oct 09, 2025
pulisher
Oct 07, 2025

Sonoma Pharmaceuticals (SNOA) Expands Reach with FDA Cosmetic Re - GuruFocus

Oct 07, 2025
pulisher
Oct 07, 2025

Sonoma Pharmaceuticals registers under FDA’s cosmetics act - Investing.com

Oct 07, 2025
pulisher
Oct 07, 2025

Sonoma Pharmaceuticals registers under FDA’s cosmetics act By Investing.com - Investing.com UK

Oct 07, 2025
pulisher
Oct 07, 2025

Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA - ACCESS Newswire

Oct 07, 2025
pulisher
Oct 07, 2025

Nearly $40B U.S. skin care market: Sonoma Pharma registers facility, lists Microcyn spray under MoCRA - Stock Titan

Oct 07, 2025
pulisher
Oct 07, 2025

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA) Sees Large Drop in Short Interest - Defense World

Oct 07, 2025
pulisher
Oct 06, 2025

Real time alert setup for Sonoma Pharmaceuticals Inc. performance2025 Short Interest & Real-Time Volume Triggers - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Is Sonoma Pharmaceuticals Inc. showing signs of accumulationBuy Signal & Breakout Confirmation Trade Signals - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Analyzing drawdowns of Sonoma Pharmaceuticals Inc. with statistical toolsWeekly Trend Summary & Risk Controlled Daily Trade Plans - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Using fundamentals and technicals on Sonoma Pharmaceuticals Inc.July 2025 Outlook & Precise Trade Entry Recommendations - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Developing predictive dashboards with Sonoma Pharmaceuticals Inc. dataJuly 2025 Action & Weekly Return Optimization Alerts - newser.com

Oct 03, 2025

Sonoma Pharmaceuticals Inc Stock (SNOA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.28
price up icon 0.40%
$10.02
price up icon 0.96%
drug_manufacturers_specialty_generic RDY
$14.00
price up icon 0.18%
$56.87
price up icon 5.03%
$138.10
price up icon 0.45%
$439.50
price up icon 1.26%
Cap:     |  Volume (24h):